Inventor · disambiguated record
Hirofumi Higuchi
Also filed as: HIGUCHI HIROFUMI
9 granted patents·2 pending applications·101 citations·filing 1994–2019
86Inventor score
Files withASTELLAS PHARMA INC2CHEMO SERO THERAPEUT RES INST2JURIDICAL FDN THE CHEMO SERO THERAPEUTIC RES INST1KM BIOLOGICS CO LTD1MURAKAMI TOSHIO1
Top patents by PatentIndex Score
11 records- 0183US7807161B2Humanized anti-human osteopontin antibodyASTELLAS PHARMA INC·Filed 2007·Granted Oct 5, 2010·8 cites·13 claims
- 0282US7241873B2Recombinant anti-osteopontin antibody and use thereofASTELLAS PHARMA INC·Filed 2002·Granted Jul 10, 2007·21 cites·7 claims
- 0377US12227563B2Anti-IGF-I receptor humanized antibodyTEIJIN PHARMA LTD·Filed 2019·Granted Feb 18, 2025·1 cites·6 claims
- 0475US6114143AAnti-HIV monoclonal antibodyCHEMO SERO THERAPEUT RES INST·Filed 1994·Granted Sep 5, 2000·40 cites·18 claims
- 0572US8715655B2Human anti-α9 integrin antibodyTORIKAI MASAHARU·Filed 2008·Granted May 6, 2014·3 cites·10 claims
- 0672US6777540B1Humanized immunoglobulin reacting specifically with Fas ligand or active fragments thereof and region inducing apoptosis originating in Fas ligandOKUMURA KO·Filed 1997·Granted Aug 17, 2004·27 cites·9 claims
- 0767US10604562B2Anti-transthyretin humanized antibodyKM BIOLOGICS CO LTD·Filed 2015·Granted Mar 31, 2020·1 cites·16 claims
- 0857US2011014193A1Humanized anti-human alpha 9-integrin antibodyJURIDICAL FDN THE CHEMO SERO THERAPEUTIC RES INST·Filed 2009·Application pending·0 cites
- 0955US8603476B2Humanized anti-human α9-integrin antibodyUEHARA KENJI·Filed 2009·Granted Dec 10, 2013·0 cites·14 claims
- 1052US8332159B2Method for enhancing efficacy of preparation of monoclonal antibodyMURAKAMI TOSHIO·Filed 2004·Granted Dec 11, 2012·0 cites·3 claims
- 1135US2008064061A1Yeast PromoterCHEMO SERO THERAPEUT RES INST·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hirofumi Higuchi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →